U.S. troops are helping the Border Patrol with expanded surveillance and intelligence efforts along the nearly 2,000-mile ...
Johnson & Johnson (NYSE:JNJ) on Friday announced a Phase 3 trial win for its anti-inflammatory therapy Tremfya, highlighting ...